go back

Massachusetts rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $436,516 · 10th–90th $436,516–$436,5160%50%100%$436,516Professionalmedian $630,957 · 10th–90th $630,957–$630,9570%50%100%$630,957$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
AllWays Health Partners
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$436,515.83 / $436,515.83 / $436,515.83
AllWays Health Partners
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$630,957.34 / $630,957.34 / $630,957.34
Mass General Brigham
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$436,515.83 / $436,515.83 / $436,515.83
Mass General Brigham
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$630,957.34 / $630,957.34 / $630,957.34